litlas
Log inCreate account

Christopher G. Wood

Active 1997–2023

125
Papers
19,686
Citations
86
h-index
125
i10-index

Citations

Citations per year for Christopher G. Wood1982: 1 citations1986: 1 citations1997: 1 citations1998: 2 citations1999: 3 citations2000: 8 citations2001: 10 citations2002: 11 citations2003: 7 citations2004: 14 citations2005: 24 citations2006: 36 citations2007: 45 citations2008: 68 citations2009: 120 citations2010: 151 citations2011: 200 citations2012: 183 citations2013: 114 citations2014: 90 citations2015: 106 citations2016: 106 citations2017: 151 citations2018: 123 citations2019: 570 citations2020: 645 citations2021: 573 citations2022: 449 citations2023: 339 citations2024: 534 citations2025: 203 citations2026: 1 citations1983–1985: no citations, so these years are not shown1987–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,640 citing papers, 23.3% of this breakdownChina: 889 citing papers, 12.6% of this breakdownItaly: 490 citing papers, 7% of this breakdownFrance: 367 citing papers, 5.2% of this breakdownGermany: 360 citing papers, 5.1% of this breakdownUnited Kingdom: 355 citing papers, 5% of this breakdownCanada: 281 citing papers, 4% of this breakdownJapan: 268 citing papers, 3.8% of this breakdownNetherlands: 202 citing papers, 2.9% of this breakdownSpain: 194 citing papers, 2.7% of this breakdownAustria: 161 citing papers, 2.3% of this breakdownAustralia: 135 citing papers, 1.9% of this breakdown
0%23.3%Other 24.2%

Institutions

Fields

  • Medicine68.4%
  • Biochemistry, Genetics and Molecular Biology22.6%
  • Immunology and Microbiology5.1%
  • Engineering0.9%
  • Computer Science0.7%
  • Agricultural and Biological Sciences0.4%
  • Other1.9%

Topics

  • Renal cell carcinoma treatment14.8%
  • Bladder and Urothelial Cancer Treatments7.1%
  • Renal and related cancers4.9%
  • Ferroptosis and cancer prognosis3.7%
  • Cancer Immunotherapy and Biomarkers3.4%
  • Cancer Genomics and Diagnostics2.9%
  • Other63.2%

Coauthors

All papers

Open in search
  1. Epidemiology of Renal Cell Carcinoma

    Authors: Umberto Capitanio, Karim Bensalah, Axel Bex, Stephen A. Boorjian, Freddie Bray, Jonathan Coleman, John L. Gore, Maxine Sun, Christopher G. Wood, Paul Russo - European Urology 2018 cited by 1,655

  2. Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

    Authors: Vitaly Margulis, Shahrokh F. Shariat, Surena F. Matin, Ashish M. Kamat, Richard Zigeuner, Eiji Kikuchi, Yair Lotan, Alon Z. Weizer, Jay D. Raman, Christopher G. Wood - Cancer 2009 cited by 1,134

  3. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

    Authors: Nizar M. Tannir, Eric Jonasch, Laurence Albigès, Emre Altinmakas, Chaan S. Ng, Surena F. Matin, Xuemei Wang, Wei Qiao, Zita Dubauskas Lim, Pheroze Tamboli, Priya Rao, Kanishka Sircar, José A. Karam, David F. McDermott, Christopher G. Wood, Toni K. Choueiri - European Urology 2015 cited by 360

  4. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

    Authors: Naomi B. Haas, Judith Manola, Robert G. Uzzo, Keith T. Flaherty, Christopher G. Wood, Christopher J. Kane, Michael A.S. Jewett, Janice P. Dutcher, Michael B. Atkins, Michael Pins, George Wilding, David Cella, Lynne I. Wagner, Surena F. Matin, Timothy M. Kuzel, Wade J. Sexton, Yu-Ning Wong, Toni K. Choueiri, Роберто Пили, Igor Puzanov, Manish Kohli, Walter M. Stadler, Michael A. Carducci, Robert Coomes, Robert S. DiPaola - The Lancet 2016 cited by 638

  5. Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development

    Authors: Zhen‐Dong Xiao, Leng Han, Hyemin Lee, Li Zhuang, Yilei Zhang, Joelle Baddour, Deepak Nagrath, Christopher G. Wood, Jian Gu, Xifeng Wu, Han Liang, Boyi Gan - Nature Communications 2017 cited by 223

  6. The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)

    Authors: Brian I. Rini, Dena Battle, Robert A. Figlin, Daniel J. George, Hans J. Hammers, Tom Hutson, Eric Jonasch, Richard W. Joseph, David F. McDermott, Robert J. Motzer, Sumanta K. Pal, Allan J. Pantuck, David I. Quinn, Virginia Seery, Martin H. Voss, Christopher G. Wood, Laura S. Wood, Michael B. Atkins - Journal for ImmunoTherapy of Cancer 2019 cited by 262

  7. Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma

    Authors: Matthew T. Campbell, Surena F. Matin, Alda L. Tam, Rahul A. Sheth, Kamran Ahrar, Rebecca S. Tidwell, Priya Rao, José A. Karam, Christopher G. Wood, Nizar M. Tannir, Eric Jonasch, Jianjun Gao, Amado J. Zurita, Amishi Y. Shah, Sonali Jindal, Fei Duan, Sreyashi Basu, Hong Chen, Alexsandra Espejo, James P. Allison, Shalini S. Yadav, Padmanee Sharma - Nature Communications 2021 cited by 60

  8. Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma

    Authors: Pavlos Msaouel, Gabriel G. Malouf, Xiaoping Su, Hui Yao, Durga Nand Tripathi, Melinda Soeung, Jianjun Gao, Priya Rao, Cristian Coarfa, Chad J. Creighton, Jean‐Philippe Bertocchio, Selvi Kunnimalaiyaan, Asha S. Multani, Jorge Blando, Rong He, Daniel D. Shapiro, Luigi Perelli, Sanjana Srinivasan, Federica Carbone, Patrick G. Pilié, Menuka Karki, Riyad N. H. Seervai, Bujamin Vokshi, Dolores López‐Terrada, Emily H. Cheng, Ximing Tang, Wei Lü, Ignacio I. Wistuba, Timothy C. Thompson, Irwin Davidson, Virginia Giuliani, Katharina Schlacher, Alessandro Carugo, Timothy P. Heffernan, Padmanee Sharma, José A. Karam, Christopher G. Wood, Cheryl L. Walker, Giannicola Genovese, Nizar M. Tannir - Cancer Cell 2020 cited by 142

  9. Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

    Authors: Lijun Zhou, X-D Liu, Mingli Sun, Xian Zhang, Polina German, Shanshan Bai, Zhiyong Ding, Nizar M. Tannir, Christopher G. Wood, Surena F. Matin, José A. Karam, Pheroze Tamboli, Kanishka Sircar, Priya Rao, Erinn B. Rankin, Douglas Laird, Anh Hoang, Cheryl L. Walker, Amato J. Giaccia, Eric Jonasch - Oncogene 2015 cited by 393

  10. Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation

    Authors: Andres Correa, Opeyemi A. Jegede, Naomi B. Haas, Keith T. Flaherty, Michael R. Pins, Edward M. Messing, Judith Manola, Christopher G. Wood, Christopher J. Kane, Michael A.S. Jewett, Janice P. Dutcher, Robert S. DiPaola, Michael A. Carducci, Robert G. Uzzo - Journal of Clinical Oncology 2019 cited by 153

  11. Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer

    Authors: Sophie J. Cowman, Daniel G. Fuja, Xian-De Liu, Rebecca S. Tidwell, Neelima Kandula, Deepika Sirohi, Archana Agarwal, Lyska L. Emerson, Sheryl R. Tripp, Jeffrey S. Mohlman, Miekan Stonhill, Guillermina Garcia, Christopher J. Conley, Adam A. Olalde, Timothy Sargis, Adela Ramírez‐Torres, José A. Karam, Christopher G. Wood, Kanishka Sircar, Pheroze Tamboli, Kenneth M. Boucher, Benjamin L. Maughan, Benjamin T. Spike, Thai H. Ho, Neeraj Agarwal, Eric Jonasch, Mei Yee Koh - Clinical Cancer Research 2020 cited by 83

  12. Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

    Authors: Jean‐Jacques Patard, Emmanuelle Leray, Nathalie Rioux‐Leclercq, Luca Cindolo, Vincenzo Ficarra, Amnon Zisman, Alexandre de la Taille, Jacques Tostain, Walter Artibani, C.C. Abbou, Bernard Lobel, F. Guillé, Dominique Chopin, Peter F.A. Mulders, Christopher G. Wood, David A. Swanson, Robert A. Figlin, Arie S. Belldegrun, Allan J. Pantuck - Journal of Clinical Oncology 2005 cited by 754

  13. Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma

    Authors: Robert A. Figlin, Nizar M. Tannir, Robert G. Uzzo, Scott S. Tykodi, David Y.T. Chen, Viraj A. Master, Anil Kapoor, Daniel A. Vaena, William T. Lowrance, Gennady Bratslavsky, Mark DeBenedette, Alicia Gamble, Ana Plachco, Marcus S. Norris, Joe Horvatinovich, Irina Y. Tcherepanova, Charles A. Nicolette, Christopher G. Wood - Clinical Cancer Research 2020 cited by 78

  14. Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma

    Authors: José A. Karam, Pavlos Msaouel, Cara Haymaker, Surena F. Matin, Matthew T. Campbell, Amado J. Zurita, Amishi Y. Shah, Ignacio I. Wistuba, Enrica Marmonti, Dzifa Y. Duose, Edwin R. Parra, Luisa M. Solis Soto, Caddie Laberiano-Fernández, Marisa Lozano, Alice Abraham, Max Hallin, Curtis D. Chin, Peter Olson, Hirak Der‐Torossian, Xiaohong Yan, Nizar M. Tannir, Christopher G. Wood - Nature Communications 2023 cited by 48

  15. Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study

    Authors: Jean‐Jacques Patard, Hyung L. Kim, John S. Lam, Frederick J. Dorey, Allan J. Pantuck, Amnon Zisman, Vincenzo Ficarra, Ken‐ryu Han, Luca Cindolo, Alexandre de la Taille, Jacques Tostain, Walter Artibani, Colin P. Dinney, Christopher G. Wood, David A. Swanson, C.C. Abbou, Bernard Lobel, Peter F.A. Mulders, Dominique Chopin, Robert A. Figlin, Arie S. Belldegrun - Journal of Clinical Oncology 2004 cited by 420

  16. A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy

    Authors: Tobias Klatte, Vincenzo Ficarra, Christian Gratzke, Jihad Kaouk, Alexander Kutikov, Veronica Macchi, Alexandre Mottrie, F. Porpiglia, James Porter, Craig Rogers, Paul Russo, R. Houston Thompson, Robert G. Uzzo, Christopher G. Wood, Inderbir S. Gill - European Urology 2015 cited by 286

  17. Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes

    Authors: Gabriel G. Malouf, Xiaoping Su, Hui Yao, Jianjun Gao, Liangwen Xiong, Qiuming He, Éva Compérat, Jérôme Couturier, Vincent Molinié, Bernard Escudier, Philippe Camparo, Denaha J. Doss, Erika J. Thompson, David Khayat, Christopher G. Wood, Willie Yu, Bin Tean Teh, John N. Weinstein, Nizar M. Tannir - Clinical Cancer Research 2014 cited by 141

  18. Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature

    Authors: Giovanni Lughezzani, Maximilian Burger, Vitaly Margulis, Surena F. Matin, Giacomo Novara, Morgan Rouprêt, Shahrokh F. Shariat, Christopher G. Wood, Richard Zigeuner - European Urology 2012 cited by 431

  19. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center

    Authors: Montserrat Ayala‐Ramirez, Sina Jasim, Lei Feng, Shamim Ejaz, Ferhat Denız, Naifa L. Busaidy, Steven G. Waguespack, Aung Naing, Kanishka Sircar, Christopher G. Wood, Lance C. Pagliaro, Camilo Jiménez, Rena Vassilopoulou‐Sellin, Mouhammed Amir Habra - European Journal of Endocrinology 2013 cited by 286

  20. Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

    Authors: José A. Karam, Catherine Devine, Diana L. Urbauer, Marisa Lozano, Tapati Maity, Kamran Ahrar, Pheroze Tamboli, Nizar M. Tannir, Christopher G. Wood - European Urology 2014 cited by 173

  21. Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review

    Authors: Idir Ouzaïd, Umberto Capitanio, Michael Staehler, Christopher G. Wood, Bradley C. Leibovich, Börje Ljungberg, Hendrik Van Poppel, Karim Bensalah - European Urology Oncology 2018 cited by 122

  22. Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions

    Authors: Aly‐Khan A. Lalani, Bradley A. McGregor, Laurence Albigès, Toni K. Choueiri, Robert J. Motzer, Thomas Powles, Christopher G. Wood, Axel Bex - European Urology 2018 cited by 251

  23. Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma

    Authors: Alejandro Román-Gonzaléz, Shouhao Zhou, Montserrat Ayala‐Ramirez, Chan Shen, Steven G. Waguespack, Mouhammed Amir Habra, José A. Karam, Nancy D. Perrier, Christopher G. Wood, Camilo Jiménez - Annals of Surgery 2017 cited by 107

  24. The Impact of Targeted Molecular Therapies on the Level of Renal Cell Carcinoma Vena Caval Tumor Thrombus

    Authors: Nicholas G. Cost, Scott E. Delacroix, Joshua Sleeper, Paul Smith, Ramy F. Youssef, Brian F. Chapin, José A. Karam, Stephen H. Culp, E. Jason Abel, James Brugarolas, Ganesh V. Raj, Arthur I. Sagalowsky, Christopher G. Wood, Vitaly Margulis - European Urology 2011 cited by 210